Metabio is a biotechnology firm offering data management platforms for biobanks. It supports the integration and annotation of longitudinal biosample data, including electronic health records and research protocols. Its AI-MetaBloQ platform, a decentralized marketplace for data related to human biosamples applies blockchain to facilitate secure data exchange among stakeholders in the biosample usage chain.
Number of investors
11st Round
Jul 31, 2024
Last Round
Jul 31, 2024
| Round | Source | |||||
|---|---|---|---|---|---|---|
| 1 | Jul 31, 2024 | -- | -- | Pro |